Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons
Article in Therapeutic Advances in Neurological Disorders (January 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Ofatumumab – the first fully human monoclonal antibody approved for the treatment of multiple sclerosis
Article in Неврология, нейропсихиатрия, психосоматика (December 2023)
Immunological outcomes of autologous hematopoietic stem cell transplantation for multiple sclerosis: a systematic review
Article in Annals of Medicine and Surgery (November 2023)